Simon J Dean

Dr. Simon J Dean

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2011 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
SDSimon J Dean
Simon J Dean
APAlex Petty
Alex Petty
Simon SwiftSimon Swift
Simon Swift
JMJennifer J McGhee
Jennifer J McGhee
ASAnant Sharma
Anant Sharma
JCJennifer P Craig
Jennifer P Craig

11 May 2022 in The Ocular Surface
Verified
Journal Article
Open access
SMSanjay Marasini
Sanjay Marasini
SDSimon J Dean
Simon J Dean
Simon SwiftSimon Swift
Simon Swift
JPJanesha Perera
Janesha Perera
Ilva RupenthalIlva Rupenthal
Ilva Rupenthal
Jennifer P CraigJennifer P Craig
Jennifer P Craig
Preclinical evaluation of the therapeutic potential of antimicrobial 265 nm UVC for infectious keratitis. Four experiments explored UVC: 1) impact on bacterial and fungal lawns on agar, in individual or mixed culture, 2) bacterial inactivation dose in an in vitro deep corneal infection model, 3) dose validation in an ex vivo porcine keratitis model and 4) efficacy in a masked, randomised, controlled murine keratitis trial using bioluminescent Pseudomonas aeruginosa. Minimum effective UVC exposures ranged between 2 s and 5 s for lawn bacteria and fungi in individual or mixed culture. Significant P. aeruginosa growth inhibition in the in vitro infection model was achieved with 15 s UVC, that resulted in a >3.5 log10 reduction of bacteria in a subsequent ex vivo keratitis model (p < 0.05). Bioluminescence fell below baseline levels in all treated animals, within 8 h of treatment (p < 0.05), in the in vivo study. Re-epithelialisation with corneal clarity occurred within 24 h in 75% of UVC-treated cases, with no relapse at 48 h. On plating, bacteria were recovered only from untreated controls. UVC inhibited all tested bacteria and fungi, including mixed culture and strains linked to antibiotic resistance, in vitro, with exposures of ≤ 5 s. In vitro and ex vivo testing confirmed therapeutic potential of 15 s UVC. In vivo, 15 s UVC administered in two doses, 4 h apart, proved effective in treating murine bacterial keratitis.

18 August 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
SMSanjay Marasini
Sanjay Marasini
Jennifer P CraigJennifer P Craig
Jennifer P Craig
SDSimon J Dean
Simon J Dean
LLLeon Gerald Leanse
Leon Gerald Leanse
There have been multiple reports of eye infections caused by antibiotic-resistant bacteria, with increasing evidence of ineffective treatment outcomes from existing therapies. With respect to corneal infections, the most commonly used antibiotics (fluoroquinolones, aminoglycosides, and cephalosporines) are demonstrating reduced efficacy against bacterial keratitis isolates. While traditional methods are losing efficacy, several novel technologies are under investigation, including light-based anti-infective technology with or without chemical substrates, phage therapy, and probiotics. Many of these methods show non-selective antimicrobial activity with potential development as broad-spectrum antimicrobial agents. Multiple preclinical studies and a limited number of clinical case studies have confirmed the efficacy of some of these novel methods. However, given the rapid evolution of corneal infections, their treatment requires rapid institution to limit the impact on vision and prevent complications such as scarring and corneal perforation. Given their rapid effects on microbial viability, light-based technologies seem particularly promising in this regard.

1 April 2009 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
ENElena S. Novitskaya
Elena S. Novitskaya
SDSimon J Dean
Simon J Dean
JMJonathan E. Moore
Jonathan E. Moore
TMTara Moore
Tara Moore
SNSonali Nagendran
Sonali Nagendran
ASAnant Sharma
Anant Sharma

20 May 2022 in Contact Lens and Anterior Eye
Verified
Journal Article
Closed access
WSWilliam Shew
William Shew
AMAlex Müntz
Alex Müntz
SDSimon J Dean
Simon J Dean
HPHeiko Pult
Heiko Pult
MWMichael T.M. Wang
Michael T.M. Wang
Jennifer P CraigJennifer P Craig
Jennifer P Craig

26 May 2007 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
SDSimon J Dean
Simon J Dean
JRJonathan Ross
Jonathan Ross
EKEwan Kemp
Ewan Kemp